“Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer”
Extract from abstract: Accurate delivery of stereotactic body radiotherapy (SBRT) to pancreatic tumors relies on successful EUS-guided placement of fiducial markers. …A retrospective chart review was performed for all (n = 82) PC patients referred for EUS-guided fiducial placement by a single endosonographer at a tertiary cancer center (i.e. The University of Texas MD Anderson Cancer Center). Data regarding EUS-related technical details, SBRT characteristics, adverse events, and continuous visibility of fiducials were recorded and analyzed.
Extract from results: …Gold Anchor (Naslund Medical AB, Huddinge, Sweden) 0.28 mm × 20 mm fiducial markers were used in 64 patients (78%).
Conclusion: …EUS-guided fiducial placement is a safe and feasible procedure with a measured success rate of 97% in patients with locally advanced or borderline resectable PDAC, according to our study.